Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T F Kennedy

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Gut|January 15, 2018
Liver sampling: a vital window into HBV pathogenesis on the path to functional cureUpkar S Gill, Laura J Pallett, Patrick T F Kennedy, et al.
JHEP Reports : Innovation in Hepatology|May 4, 2023
Utility of novel viral and immune markers in predicting HBV treatment endpoints: A systematic review of treatment discontinuation studiesGeorgia Zeng, Apostolos Koffas, Lung-Yi Mak, et al.
Viruses|May 5, 2017
Immune Tolerant Chronic Hepatitis B: The Unrecognized RisksPatrick T F Kennedy, Samuel Litwin, Grace E Dolman, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 25, 2008
Potential and limitations of lamivudine monotherapy in chronic hepatitis B: evidence from genotypingPatrick T F Kennedy, Natalie Phillips, Jaya Chandrasekhar, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
The co-existence of NAFLD and CHB is associated with suboptimal viral and biochemical response to CHB antiviral therapy: a systematic review and meta-analysisGeorgia Zeng, Benjamin R Holmes, Saleh A Alqahtani, et al.
Frontiers in Microbiology|September 19, 2022
Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cureRomina Salpini, Stefano D'Anna, Livia Benedetti, et al.
Hepatology International|February 27, 2021
Chronic hepatitis B: the demise of the 'inactive carrier' phaseApostolos Koffas, Manoj Kumar, Upkar S Gill, et al.
Journal of Virology|February 26, 2005
Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infectionOrnella Franzese, Patrick T F Kennedy, Adam J Gehring, et al.
Surgical Endoscopy|January 30, 2010
The safety and utility of prophylactic pancreatic duct stents in the prevention of post-ERCP pancreatitis: an analysis of practice in a single UK tertiary referral centerPatrick T F Kennedy, Evangelos Russo, Naveenta Kumar, et al.
Journal of Viral Hepatitis|December 18, 2008
The expression and function of NKG2D molecule on intrahepatic CD8+ T cells in chronic viral hepatitisP T F Kennedy, A J Gehring, A Nowbath, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Gut|January 15, 2018
Liver sampling: a vital window into HBV pathogenesis on the path to functional cureUpkar S Gill, Laura J Pallett, Patrick T F Kennedy, et al.
JHEP Reports : Innovation in Hepatology|May 4, 2023
Utility of novel viral and immune markers in predicting HBV treatment endpoints: A systematic review of treatment discontinuation studiesGeorgia Zeng, Apostolos Koffas, Lung-Yi Mak, et al.
Viruses|May 5, 2017
Immune Tolerant Chronic Hepatitis B: The Unrecognized RisksPatrick T F Kennedy, Samuel Litwin, Grace E Dolman, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 25, 2008
Potential and limitations of lamivudine monotherapy in chronic hepatitis B: evidence from genotypingPatrick T F Kennedy, Natalie Phillips, Jaya Chandrasekhar, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
The co-existence of NAFLD and CHB is associated with suboptimal viral and biochemical response to CHB antiviral therapy: a systematic review and meta-analysisGeorgia Zeng, Benjamin R Holmes, Saleh A Alqahtani, et al.
Frontiers in Microbiology|September 19, 2022
Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cureRomina Salpini, Stefano D'Anna, Livia Benedetti, et al.
Hepatology International|February 27, 2021
Chronic hepatitis B: the demise of the 'inactive carrier' phaseApostolos Koffas, Manoj Kumar, Upkar S Gill, et al.
Journal of Virology|February 26, 2005
Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infectionOrnella Franzese, Patrick T F Kennedy, Adam J Gehring, et al.
Surgical Endoscopy|January 30, 2010
The safety and utility of prophylactic pancreatic duct stents in the prevention of post-ERCP pancreatitis: an analysis of practice in a single UK tertiary referral centerPatrick T F Kennedy, Evangelos Russo, Naveenta Kumar, et al.
Journal of Viral Hepatitis|December 18, 2008
The expression and function of NKG2D molecule on intrahepatic CD8+ T cells in chronic viral hepatitisP T F Kennedy, A J Gehring, A Nowbath, et al.
Pageof 8